Effectiveness of palivizumab immunoprophylaxis in preterm infants against respiratory syncytial virus disease in Qatar.

about

Effectiveness of palivizumab immunoprophylaxis in preterm infants against respiratory syncytial virus disease in Qatar.

Item

http://www.wikidata.org/entity/Q49474232

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Effectiveness of palivizumab i ...... cytial virus disease in Qatar.

@en

Effectiveness of palivizumab i ...... cytial virus disease in Qatar.

@nl

type

Item

label

Effectiveness of palivizumab i ...... cytial virus disease in Qatar.

@en

Effectiveness of palivizumab i ...... cytial virus disease in Qatar.

@nl

prefLabel

Effectiveness of palivizumab i ...... cytial virus disease in Qatar.

@en

Effectiveness of palivizumab i ...... cytial virus disease in Qatar.

@nl

P1476

Effectiveness of palivizumab i ...... ncytial virus disease in Qatar

@en

P2093

Ahmad Abushahin

http://www.w3.org/2001/XMLSchema#string

Amjad Tuffaha

http://www.w3.org/2001/XMLSchema#string

P2860

Monoclonal antibody for reducing the risk of respiratory syncytial virus infection in children

Bronchopulmonary dysplasia

Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection

Use of data linkage to investigate the aetiology of acute lower respiratory infection hospitalisations in children.

Risk of primary infection and reinfection with respiratory syncytial virus.

Palivizumab prophylaxis of respiratory syncytial virus disease from 1998 to 2002: results from four years of palivizumab usage.

Palivizumab prophylaxis and hospitalization for respiratory syncytial virus disease in the Stockholm infant population, 1999 through 2002.

Respiratory syncytial virus activity-- United States, July 2007-December 2008.

Palivizumab prophylaxis of respiratory syncytial virus disease in 2000-2001: results from The Palivizumab Outcomes Registry.

P304

41-46

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/IJGM.S156078

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ibrahim A Janahi

P577

2018-01-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29430194

http://www.w3.org/2001/XMLSchema#string

P921

preterm infant

P932

5797460

http://www.w3.org/2001/XMLSchema#string